Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q3 2022 Ossur hf Earnings Call Transcript

Oct 25, 2022 / 07:00AM GMT
Release Date Price: kr32.95 (-1.79%)
Operator

Good day, and thank you for standing by. Welcome to the Ãssur Q3 Results 2022 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Sveinn Solvason and Gudny Arna. Sveinn, please go ahead.

Sveinn Solvason;ssur hf.;President;CEO
Ã

&

Thank you very much. I would like to welcome you to the Ãssur investor conference call where we will cover the results for the third quarter of 2022. My name is Sveinn Solvason, and I'm the President and CEO. And with me here today is Arna Sveinsdottir, our CFO.

We will go through the highlights for the quarter and a question-and-answer session will then follow. If we go to the next slide, please. Sales amounted to $177 million, which corresponds to 4% organic growth. Sales were strong in APAC, both in China after lockdowns in quarter 2 and in Australia, which is retaining ground. Sales growth in Americas was driven by strong prosthetic sales, while after

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot